首页|新诊断2型糖尿病患者葡萄糖目标范围内时间与糖化血红蛋白的相关性

新诊断2型糖尿病患者葡萄糖目标范围内时间与糖化血红蛋白的相关性

扫码查看
目的 探讨新诊断2型糖尿病(T2DM)患者短期治疗后葡萄糖目标范围内时间(TIR)与3个月后糖化血红蛋白(HbA1c-3m)的相关性.方法 本研究为横断面研究.选取2018年1月至2022年9月于内蒙古自治区人民医院内分泌科住院的新诊断并开始治疗同时接受3个月随访、资料信息完整的94例T2DM患者作为研究对象.按照血糖所要达到的不同目标范围将TIR分为3组(TIR1:血糖在3.9~10.0 mmol/L之间的TIR,TIR2:血糖在3.9~7.8 mmol/L之间的TIR,TIR3:空腹、餐前或睡前血糖<6.1 mmol/L同时餐后2h血糖<8.0 mmol/L范围内的TIR),以HbA1c-3m是否<6.5%将研究对象分为两组,比较两组的基线资料以及不同目标水平TIR的差异,分别采用Spearman相关分析、二元logistic回归模型分析各基线指标、短期治疗后3组TIR分别与HbA1c-3m的相关性,并绘制受试者工作特征(ROC)曲线分别评估短期治疗后不同TIR对HbA1c-3m的预测价值.结果 HbA1c-3m<6.5%组与 HbA1c-3m≥6.5%组的 TIR1[81.0(67.5,94.6)%比 71.4(51.7,85.7)%]、TIR2[57.7(29.7,70.8)%比40.9(22.4,52.3)%]、TIR3[23.8(10.2,39.5)%比 13.0(4.8,25.0)%]比较差异均有统计学意义.在所有新诊断的T2DM患者中,TIR1、TIR2、TIR3与HbA1c-3m[6.4(6.1,6.9)%]均呈负相关(r值分别为-0.322、-0.348、-0.303,均P<0.01).在校正相关混杂因素后,TIR1(OR=1.021,95%C/:1.002~1.041;P=0.034)、TIR2(OR=1.024,95%CI:1.006~1.043;P=0.011)、TIR3(OR=1.037,95%CI:1.010~1.065;P=0.008)均与HbA1c-3m独立相关.以HbA1c-3m<6.5%为目标值时,ROC曲线下面积分别为:TIR1为0.639(95%CI:0.528~0.751)、TIR2 为 0.671(95%CI:0.560~0.782)、TIR3 为 0.659(95%CI:0.549~0.770),当 以HbA1c-3m<7.0%为目标值时,ROC 曲线下面积分别为:TIR1 为 0.730(95%CI:0.619~0.841)、TIR2 为0.744(95%CI:0.642~0.846)、TIR3 为 0.701(95%CI:0.588~0.814),三者间曲线下面积差异均无统计学意义.结论 对于新诊断的T2DM患者短期治疗后TIR与3个月后HbA1c水平呈负相关,对其具有良好的预测价值.
Correlation between time in range and glycated hemoglobin in patients with newly-diagnosed type 2 diabetes mellitus
Objective To explore the correlation between time in range(TIR)after short-term treatment and glycated hemoglobin after 3 months(HbA1c-3m)in patients with newly-diagnosed type 2 diabetes mellitus(T2DM).Methods In this cross-sectional study,a total of 94 patients with newly-diagnosed T2DM who received treatment in the Department of Endocrinology of Inner Mongolia Autonomous Region People's Hospital were enrolled from January 2018 to September 2022.The patients were followed-up for 3 months and had complete medical record.TIR was divided into three groups according to different target ranges of blood glucose(TIR1:TIR with blood glucose between 3.9 and 10.0 mmol/L,TIR2:TIR with blood glucose between 3.9 and 7.8 mmol/L,TIR3:TIR with fasting,premeal or bedtime blood glucose<6.1 mmol/L and 2 h postprandial blood glucose<8.0 mmol/L).The patients were divided into two groups based on whether their HbA1c-3m level was less than 6.5%,and the baseline data and variations in TIR for distinct target glucose levels were compared between the two groups.Spearman's correlation analysis and binary logistic regression analysis were used to analyze the relationship between baseline indicators,TIR after short-term treatment and HbA1c-3m.Receiver operating characteristic curve(ROC)was drawn to evaluate the predictive ability of different TIR after short-term therapy for HbA1c-3m.Results There were statistically significant differences in TIR1[81.0(67.5,94.6)%vs 71.4(51.7,85.7)%],TIR2[57.7(29.7,70.8)%vs 40.9(22.4,52.3)%]and TIR3[23.8(10.2,39.5)%vs 13.0(4.8,25.0)%]between patients with a HbA1c-3m<6.5%and patients with a HbA1c-3m≥6.5%(all P<0.05).Spearman correlation analysis showed that among all the patients with newly-diagnosed T2DM,TIR1,TIR2 and TIR3 were all negatively correlated with HbA1c-3m[6.4(6.1,6.9)%](r=-0.322,-0.348,-0.303,respectively,all P<0.01).Logistic regression analysis showed that after adjusting for the confounding factors,TIR1(OR=1.021,95%CI:1.002-1.041;P=0.034),TIR2(OR=1.024,95%CI:1.006-1.043;P=0.011),TIR3(OR=1.037,95%CI:1.010-1.065;P=0.008)were all independently related to HbA1c-3m.When HbA1c-3m<6.5%was taken as the target value,the area under the ROC curve:TIR1 was 0.639(95%CI:0.528-0.751),TIR2 was 0.671(95%CI:0.560-0.782),TIR3 was 0.659(95%CI:0.549-0.770),respectively.When HbA1c-3m<7.0%was taken as the target value,the area under the ROC curve:TIR1 was 0.730(95%CI:0.619-0.841),TIR2 was 0.744(95%CI:0.642-0.846),TIR3 was 0.701(95%CI:0.588-0.814).There was no significant difference in the area among the three statistics(P>0.05).Conclusions For newly-diagnosed T2DM patients,TIR after short-term treatment is negatively correlated with HbA1c after 3 months and has good predictive value for it.

Diabetes mellitus,type 2Blood glucose self-monitoringGlycated hemoglobinTime in range

蒋乐、王蕾、李冬梅、奥日瀚、李云凤、高钰青、李园园、刘师伟

展开 >

内蒙古自治区人民医院内分泌科,呼和浩特 010000

内蒙古医科大学研究生院,呼和浩特 010000

山西白求恩医院内分泌科,太原 030032

糖尿病,2型 血糖自我监测 糖化血红蛋白 葡萄糖目标范围内时间

内蒙古自治区科技厅项目山西省回国留学人员资助项目山西省基础研究计划项目

2021GG01342020-18020210302123487

2024

中华健康管理学杂志
中华医学会

中华健康管理学杂志

CSTPCD北大核心
影响因子:1.004
ISSN:1674-0815
年,卷(期):2024.18(1)
  • 17